Cirrhosis is a complication of many liver disease characterized by abnormal structure and function of the liver. The aim of this study is to investigate the liver function levels by measuring Glutamate Oxaloacetate Transaminase (GOT), Glutamate Pyruvate Transaminase (GPT), Alkaline Phosphatase (ALP) and total protein (T.P) and lipid profile levels by measuring total cholesterol (TC), triglyceride (TG), low density lipoproteins (LDL) and high density lipoproteins (HDL). Seventy five individuals of Iraqi adults (25 female and 50 male) were divided into two groups: 25 normal individuals (10 female and 15 male) as control group (group1), their age range (28-60) year and 50 cirrhotic patients (20 female and 30 male), their age range (18-68) year and (35-72) year respectively (group 2). In the present study, the mean value of GOT, GPT and ALP activity were significantly higher in patients with cirrhosis disease than healthy group (p 0.01), while the mean value of T.P. level was 6.21g/dl in cirrhotic patients compared with healthy group 7.54g/dl. The findings indicate that serum (TC, TG, HDL and LDL) levels were significantly decreased (P 0.01) in cirrhotic Patients compared with healthy group. The results also indicate a positive correlation between GOT and GPT, and between ALP and both (GOT, GPT). Also, there was a positive correlation between TC and (TG, HDL and LDL) and between TG and both (HDL, LDL). This study has shown that a significant difference (P 0.05) between male and female in the mean value of T.P and TC levels and also the effect of duration of disease on Parameters was studied.
Cite this article:
Jinan Hussein Murtadha, Iman Hashim, Abdul Razzaq. Study of Liver Function and Lipid Profile Changes in Iraqi Cirrhotic patients. Research J. Pharm. and Tech. 2020; 13(4):1837-1840. doi: 10.5958/0974-360X.2020.00331.5
1. Vijaya, B.; Farid, M.; Rekha, D. and Aditi, S. 2013. Comparative study of ALT, AST, GGT and Uric acid levels in liver disease. IOSR Journal of Dental and Medical Science (IOSR-JDMS), 7(5): 72-75.
2. Murphy, S.; SU, J. and Kochane, K. 2013. Deaths: final data for 2010. Natl Vital Stat Rep, 64(4): 1-117.
3. Detlef, S. and Nezam, H. 2008. Liver cirrhosis. Lancet, 8:838-851.
4. Schmidt, F.1978. Rational for the use of enzyme determinations in the diagnosis of Liver disease. In: Demers, L.M. and L.M. show (Eds), elevation of liver functions: A multifaceted approach to clinical diagnosis. Urban and Schwarzenberg, Baltimore, PP:51-7.
5. Ghany, M. and Hoofinagle, J.2005. Harrison’s principle of internal medicine, 16th edition, New York, NY: MeGraw Hill Medical: PP 1808.
6. Desmet, V. and Roskams, T.2004. Cirrhosis reversal: a duel between dogma and myth. J. Hepatol., 40: 860-7.
7. Abshagen, K.; Brensel, M.; Genz, B. et al. 2015. Foxif1 SIRNA delivery to hepatic stellate cells by DBTC Lipoplex formulations ameliorates fibrosis in liver of bile duct ligated mice. Curre Gene Ther, 15(3): 215-227.
8. Roy, S., Benz, F.; Luedde T. and Roderburg, C. 2015. The role of miRNAs in the regulation of inflammatory processes during heapto fibrogenesis. Hepatobiliary Surg Nutr, 4(1): 24-33.
9. Zohair, A.; Umair, A.; Saqib, W.; Jinma, R.; Daniel, K. et al. 2018. Liver function tests in identifying patients with liver disease. J Clin Exp Gastroenterol, 11:301-307.
10. Seidel, D. 1987. Lipoproteins in liver disease. J Clin Chem. Clin Bio chem, 25: 541-551.
11. Mehboob, F.; Ranjha, F. and Masud, S. 2007. Change in serum lipid profile among patients suffering from chronic liver disease. Annals, 13: 3-5.
12. Sanjay, k.; koelina, S.; Sumanta, C. and Jacky, G et al. 2013. A study on lipid profiles in chronic liver diseases. National J of Med Res, 3(1): 70– 72.
13. Fried wald, W.; Levy, R. and Fredrickson, B. 1990. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 36: 15-19.
14. Rifai, N.; Dufour, D. and Cooper, G. 2000. Pre analytical variation in Lipid, lipoprotein and apoliprotein testing. Rifai Nwanick GR Dominiczak M Heda. Handbook of lipoprotein testing, 161-187.
15. SAS. 2012. Statistical Analysis System, User’s Guide Statistical version 9.1thed. ASA Instrument Incorporation, Cary. N. C. USA.PP 534.
16. Essam, F. and faihaa, M. 2012. The effect of chronic liver diseases on some biochemical parameters in patient’s serum. Current Research Journal of Biological Science, 5(4): 638-642.
17. Defranchis, R. and Baveno, V. 2015. Expanding consensus in portal hypertension: Report of the Baveno VI consensus workshop: stratifying risk and individualizing care for porta hypertension. J Hepatol, 63(3): 743-52.
18. Christinal, L. 2017. How to interpret liver function tests. South Sudan Medical Journal, 10(2): 40-43.
19. Sorbi, D.; Boynton, J. and Lindor, K. 1999. The aspartate aminotransferase to alanine amino transferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. The American Journal of Gastroenterology, 94: 1018 – 1022.
20. Marth, L. and Rlando, H. 2016. Is liver enzymes release really associated with cell necrosis induced by oxidant stress. Oxid Med Cell Longer, 10: 1155-1158.
21. Nangliya, V.; Sharma, A.; Sundra, S. and Yadar, D. et al. 2015. Evaluation of lipid profile in patients with severity of the disease. Int J Recent Trends Sci Technol, 16: 79-82.
22. Hashik, P. and Kezhakkut, J. 2017. Correlation of lipid profile in patients with severity of liver disease: a cross sectional study in a tertiary care hospital. International Journal of Research in Medical Science, 5(1): 326-329.
23. Mandal, S.; Sil, K.; Chatterjee, S.; Ganguly, J.; Chaterjee, K. and Sarkar, P.et at. 2013. A study of lipid profiles in chronic liver diseases. Natl J Med Res, 3: 70- 2.
24. Jitendra, J.; Rajeev, S. and Sandeep, S. 2018. Study of lipid profile changes in cirrhosis of liver. International Journal of Science Study, 6(3): 108-114.
25. Jiang, M.; Liu, F.; Xiong, W. and Xu, F. et al .2010. Combined meld and blood lipid level in evaluating the prognosis of de compensated cirrhosis. World J Gastero enterol, 16(11): 1397 – 1401.
26. Nashaat, E. 2010. Comparative study of serum lipid profile between chronic hepatitis C Egyption patients and normal controls and the effect of viral eradication on lipid profile. Report and Opinion, 2: 14-20.
27. Petit, J.; Benichon, M.; Duvillard, L. and Minello, A. et al. 2003. Hepatitis C virus associated hypobetal lipoproteinemia is Correlated with plasma viral load, steatosis and liver fibrosis. Am J Gastroentrol , 98(5): 1150-1154.